Management of Periampullary Mass with Benign Brunner Gland Histology
For a periampullary mass showing only benign duodenal mucosa with villi and Brunner glands on histopathology, resection is generally unnecessary unless the lesion is symptomatic, large (>2 cm), or causing complications such as bleeding or obstruction. 1
Understanding the Pathology
Brunner gland hamartomas are uncommon, benign lesions arising from lobular proliferation of normal duodenal Brunner glands. 1 These lesions:
- Are typically solitary and pedunculated, potentially reaching 2-5 cm in size 1
- Represent non-neoplastic proliferations without malignant potential in the vast majority of cases 1, 2
- Can mimic neoplastic adenomatous pathology on endoscopic appearance, requiring careful optical evaluation and pathologic inspection 1
Clinical Decision Algorithm
Asymptomatic Lesions ≤2 cm
- No intervention required - observation is appropriate 1, 2
- Document the lesion's relationship to the major and minor papilla with photodocumentation to ensure no papillary involvement 1
- Confirm benign histology shows no dysplasia (rare cases of dysplasia have been reported) 2, 3
Symptomatic Lesions or Size >2 cm
Consider endoscopic or surgical resection if the lesion causes: 1, 2
- Partial duodenal obstruction 1, 3, 4
- Gastrointestinal bleeding or melena 3, 5, 6
- Abdominal pain related to the mass 3, 4
- Biliary or pancreatic duct obstruction (rare but reported) 4
Resection Approach Based on Size and Location
- Pedunculated lesions: May be amenable to endoscopic polypectomy 7, 6
- Large sessile lesions (>5 cm): Often require surgical resection via transduodenal polypectomy or segmental duodenal resection 3, 4
- Periampullary location: Requires careful assessment to avoid ampullary injury; may necessitate surgical rather than endoscopic approach 4
Critical Pitfalls to Avoid
Biopsy-induced complications: While diagnostic biopsy confirmed benign histology in this case, be aware that biopsy can induce submucosal scarring that complicates subsequent endoscopic resection if later needed. 8
Bleeding risk: The duodenal location carries higher post-procedural bleeding risk than other GI sites, with risk proportional to lesion size (>25% for lesions >3 cm). 1, 2 For large symptomatic lesions requiring resection, patients should be counseled about this risk and monitored for 48 hours post-procedure. 1
Misdiagnosis of malignancy: Large Brunner gland lesions can mimic pancreatic or periampullary malignancy on imaging, potentially leading to unnecessary pancreaticoduodenectomy. 4 Endoscopic evaluation combined with endoscopic ultrasound helps establish the correct diagnosis and avoid overtreatment. 4
Incomplete histologic sampling: Ensure adequate tissue sampling, as superficial biopsies may miss deeper pathology. 7 However, in this case with confirmed benign Brunner gland histology showing normal duodenal architecture, malignancy is effectively excluded.
Follow-Up Recommendations
- For observed lesions: No specific surveillance protocol is established for benign Brunner gland lesions, but repeat endoscopy may be considered if symptoms develop 5
- After resection: Endoscopic surveillance to monitor for recurrence, though recurrence of truly benign Brunner gland lesions is uncommon 7, 5
- Acid suppression: Consider H2 antagonists or proton pump inhibitors as adjunctive therapy, as hyperacidity may contribute to Brunner gland hyperplasia 5